Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
30,742,440
-
Share change
-
-7,973,755
-
Total reported value
-
$123,259,030
-
Put/Call ratio
-
152%
-
Price per share
-
$4.01
-
Number of holders
-
67
-
Value change
-
-$78,443,042
-
Number of buys
-
27
-
Number of sells
-
56
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2022
As of 30 Sep 2022,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,742,440 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., NOMURA HOLDINGS INC, BlackRock Inc., Cederberg Capital Ltd, VANGUARD GROUP INC, MORGAN STANLEY, ARMISTICE CAPITAL, LLC, GOLDMAN SACHS GROUP INC, CANADA PENSION PLAN INVESTMENT BOARD, and BANK OF AMERICA CORP /DE/.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.